Forma Therapeutics Holdings Inc. (FMTX) NASDAQ
$20.01 - (-)
Market Cap: -
As of 10/13/22 12:00 AM EDT. Market closed.
Forma Therapeutics Holdings Inc. (FMTX)
NASDAQ
$20.01
- (-)
Market Cap: -
As of 10/13/22 12:00 AM EDT. Market closed.
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Its R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action ... read more
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Its R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Its work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Kelly Patrick F. | SVP, Chief Medical Officer | Apr 08, 2022 | Option Exercise | $5.05 | 15,000 | 75,750 | 104,884 | Apr 14, 2022, 06:10 PM |
| COOK DAVID N | SVP, Chief Scientific Officer | Feb 23, 2022 | Sale | $9.78 | 3,531 | 34,524 | 16,469 | Feb 25, 2022, 05:09 PM |
| Lee Frank D. | President and CEO | Feb 23, 2022 | Sale | $9.78 | 17,981 | 175,809 | 79,769 | Feb 25, 2022, 05:08 PM |
| Kelly Patrick F. | SVP, Chief Medical Officer | Feb 23, 2022 | Sale | $9.78 | 5,245 | 51,283 | 64,884 | Feb 25, 2022, 05:08 PM |
| Shegog Todd | SVP, Chief Financial Officer | Feb 23, 2022 | Sale | $9.78 | 5,687 | 55,605 | 22,813 | Feb 25, 2022, 05:04 PM |
| Lesser Brian Andrew | SVP, Commercial | Feb 23, 2022 | Sale | $9.78 | 3,837 | 37,516 | 17,593 | Feb 25, 2022, 05:02 PM |
| Wadlinger Mary E. | See Remarks | Feb 23, 2022 | Sale | $9.78 | 4,684 | 45,798 | 134,521 | Feb 25, 2022, 05:01 PM |
| Potts Jeannette | See Remarks | Feb 23, 2022 | Sale | $9.78 | 4,672 | 45,680 | 22,358 | Feb 25, 2022, 05:01 PM |
| Potts Jeannette | See Remarks | Dec 30, 2020 | Option Exercise | $5.05 | 3,400 | 17,170 | 3,400 | Jan 08, 2021, 04:03 PM |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 1,000,000 | 20,000,000 | 2,252,913 | Jun 25, 2020, 05:48 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 4,000,000 | 80,000,000 | 9,011,651 | Jun 24, 2020, 09:20 PM |
| Kolchinsky Peter | Director | Jun 23, 2020 | Buy | $20.00 | 4,000,000 | 80,000,000 | 9,011,651 | Jun 24, 2020, 09:19 PM |
| Owner | Relationship | Date | Value($) |
| Kelly Patrick F. | SVP, Chief Medical Officer | 04/08/2022 | 75,750 |
| COOK DAVID N | SVP, Chief Scientific Officer | 02/23/2022 | 34,524 |
| Lee Frank D. | President and CEO | 02/23/2022 | 175,809 |
| Kelly Patrick F. | SVP, Chief Medical Officer | 02/23/2022 | 51,283 |
| Shegog Todd | SVP, Chief Financial Officer | 02/23/2022 | 55,605 |
| Lesser Brian Andrew | SVP, Commercial | 02/23/2022 | 37,516 |
| Wadlinger Mary E. | See Remarks | 02/23/2022 | 45,798 |
| Potts Jeannette | See Remarks | 02/23/2022 | 45,680 |
| Potts Jeannette | See Remarks | 12/30/2020 | 17,170 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 06/23/2020 | 20,000,000 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 06/23/2020 | 80,000,000 |
| Kolchinsky Peter | Director | 06/23/2020 | 80,000,000 |